Cannabis as Medicine

Careful with CBD – Very Careful: Some CBD Creams, Patches Don’t Match Labels: Study

By Damian McNamara, MA July 25, 2022  Cannabidiol (CBD) products made from hemp have gotten more popular in recent years. But how much can you trust what the label says, compared to what really is in CBD patches, creams, and lotions? A team of investigators decided to find out. They bought 105 hemp-derived CBD topicals – products designed

Careful with CBD – Very Careful: Some CBD Creams, Patches Don’t Match Labels: Study Read More »

Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy

This is the madness you get when the largely unregulated #marijuana marketing monster is permitted to promote non-clinically trialled products with unsubstantiated claims of care and cure!  But that’s exactly what you get in a ‘vote for medicine’ framework. The short-term and intergenerational harms of this #madness is all but guaranteed. It is disturbing enough

Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy Read More »

An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom

 Published Online:19 Apr 2022 Abstract Introduction: Over-the-counter cannabidiol (CBD) products have seen unprecedented recent growth in the United Kingdom. However, analysis of these predominantly unregulated products from other countries tells us that they are often mislabeled or contain unlabeled and potentially dangerous chemicals. Thus, the aim of the present study was to analyze CBD oils available

An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom Read More »

Clearing the Smoke on Cannabis: Cannabis Use During Pregnancy & Breastfeeding

Cannabis is the second-most common psychoactive substance (after alcohol) used during pregnancy. Elements of cannabis can pass through the placenta and affect the fetus’s development. Frequent cannabis use during pregnancy is associated with low birth weight and is part of a cluster of risk factors related to other adverse birth outcomes. There are also effects

Clearing the Smoke on Cannabis: Cannabis Use During Pregnancy & Breastfeeding Read More »

Cardiovascular Effects of Marijuana & Synthetic Cannabinoids

Key points Activation of cannabinoid receptor 1 (CB1R) by endocannabinoids or synthetic ligands mediates acute haemodynamic effects and might contribute to pathology in cardiovascular disease; activation of cannabinoid receptor 2 (CB2R) exerts anti-inflammatory effects The psychoactive constituent of marijuana, Δ9‑tetrahydrocannabinol (THC), exerts its cardiovascular effects via CB1R activation; at low doses it might have beneficial

Cardiovascular Effects of Marijuana & Synthetic Cannabinoids Read More »

Sedation and Acute Encephalopathy in a Paediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

Children eating the grown-ups ‘medicinal marijuana’ Gummy Bears, being not only sedated but experiencing a disease that affects brain structure and/or function. Encephalopathy causes altered mental state and confusion – Welcome to THC – and its analogues – use! Sedation and Acute Encephalopathy in a Paediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies Abstract BACKGROUND Delta-8

Sedation and Acute Encephalopathy in a Paediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies Read More »

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

Abstract: Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer products for complementary health or recreational use. CBD has intrinsic pharmacologic effects and associated adverse drug events (ADEs) along with the potential for pharmacokinetic and pharmacodynamic drug–drug interactions (DDIs). Given CBD use among patients with complex conditions and treatment regimens, as well as

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use Read More »

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions

Abstract: Tetrahydrocannabinol (THC) is the primary psychoactive ingredient in cannabis… ‘medical’ marijuana programs have increased exposure among medically complex individuals with comorbid conditions and many co-prescribed medications. Thus, THC should be recognized as a pharmacologically complex compound with potential for drug–drug interactions and adverse drug events… THC also has broad interactions with drug-metabolizing enzymes and

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions Read More »

Cannabis Causing Cancer

Cannabis Causing Cancer Part 1 – Epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: Part 1: Complete Research here https://rdcu.be/cKfKp Conclusion: Data suggest that cannabinoids including THC and cannabidiol are important community carcinogens exceeding the effects of tobacco or alcohol. Testicular, (prostatic) and ovarian tumours indicate mutagenic

Cannabis Causing Cancer Read More »

Scroll to Top